|
⚲
|
| Keyboard |
| Advent Life Sciences Fund I LP
✚
|
|
|---|---|
| CIK # | 0001601363 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001601363] | |
| 4 | [0001601363] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Advent Life Sciences LLP | |
| Aravive Inc | |
| Advent Life Sciences Fund I LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aravive Inc VSAR
Common Stock
|
2015-01-22 | Buy | 55,000 | $17.25 | 948,750 |
|
Aravive Inc VSAR
Common Stock
|
2014-03-26 | Conversion | 1,258,086 | ||
|
Aravive Inc VSAR
Common Stock
|
2014-03-26 | Conversion | 176,813 | ||
|
Aravive Inc VSAR
Common Stock
|
2014-03-26 | Conversion | 78,228 | ||
|
Aravive Inc VSAR
Common Stock
|
2014-03-26 | Conversion | 154,178 | ||
|
Aravive Inc VSAR
Common Stock
|
2014-03-26 | Conversion | 489,253 | ||
|
Aravive Inc VSAR
Warrants to Purchase Series B Preferred Stock · derivative
|
2014-03-26 | Option exercise | 506,376 | $0.00 | |
|
Aravive Inc VSAR
Common Stock
|
2014-03-26 | Buy | 60,000 | $21.00 | 1,260,000 |
|
Aravive Inc VSAR
Series B Convertible Preferred Stock · derivative
|
2014-03-26 | Option exercise | 506,376 | $0.00 | |
|
Aravive Inc VSAR
Series B Convertible Preferred Stock · derivative
|
2014-03-26 | Conversion | 14,468,020 | $0.00 | |
|
Aravive Inc VSAR
Series C Convertible Preferred Stock · derivative
|
2014-03-26 | Conversion | 5,626,413 | $0.00 | |
|
Aravive Inc VSAR
Series D-1 Convertible Preferred Stock · derivative
|
2014-03-26 | Conversion | 2,033,350 | $0.00 | |
|
Aravive Inc VSAR
Series D-2 Convertible Preferred Stock · derivative
|
2014-03-26 | Conversion | 899,619 | $0.00 | |
|
Aravive Inc VSAR
Series E Convertible Preferred Stock · derivative
|
2014-03-26 | Conversion | 1,773,049 | $0.00 |